Press Releases Year None2023202220212020201920182017201620152014 Sep 05, 2023 Twist Bioscience to Present at Upcoming Investor Conferences Keep Reading Aug 31, 2023 Twist Bioscience Enters into Agreement with Ono Pharmaceutical to Discover Novel Antibodies for Autoimmune Diseases Keep Reading Aug 22, 2023 Twist Bioscience Releases 2023 ESG Report and Quantifies Carbon Footprint of Manufacturing a Single Gene Keep Reading Aug 07, 2023 Twist Bioscience to Present at the UBS MedTech, Tools and Genomics Summit 2023 Keep Reading Aug 04, 2023 Twist Bioscience Reports Fiscal Third Quarter 2023 Financial Results Keep Reading Jul 20, 2023 Twist Bioscience to Report Fiscal 2023 Third Quarter Financial Results on Friday, August 4, 2023 Keep Reading Jul 18, 2023 Twist Bioscience and Cancer Research Horizons Enter into Collaboration to Advance Cancer Research Keep Reading Jun 26, 2023 Twist Bioscience Publishes Preclinical Data in Diabetes Validating GLP-1R Antagonist Antibody as Potential Treatment for Congenital Hyperinsulinism Keep Reading Jun 20, 2023 Twist Bioscience Appoints Chet Gandhi as Chief Information Officer Keep Reading May 31, 2023 Twist Bioscience and CeGaT Launch RNA Fusion Panel to Advance Oncology and Precision Medicine Research Keep Reading Current page 1 Page 2 Page 3 Next page next › Last page last » Print Page Email Page Email Alerts RSS Feeds
Year None2023202220212020201920182017201620152014 Sep 05, 2023 Twist Bioscience to Present at Upcoming Investor Conferences Keep Reading Aug 31, 2023 Twist Bioscience Enters into Agreement with Ono Pharmaceutical to Discover Novel Antibodies for Autoimmune Diseases Keep Reading Aug 22, 2023 Twist Bioscience Releases 2023 ESG Report and Quantifies Carbon Footprint of Manufacturing a Single Gene Keep Reading Aug 07, 2023 Twist Bioscience to Present at the UBS MedTech, Tools and Genomics Summit 2023 Keep Reading Aug 04, 2023 Twist Bioscience Reports Fiscal Third Quarter 2023 Financial Results Keep Reading Jul 20, 2023 Twist Bioscience to Report Fiscal 2023 Third Quarter Financial Results on Friday, August 4, 2023 Keep Reading Jul 18, 2023 Twist Bioscience and Cancer Research Horizons Enter into Collaboration to Advance Cancer Research Keep Reading Jun 26, 2023 Twist Bioscience Publishes Preclinical Data in Diabetes Validating GLP-1R Antagonist Antibody as Potential Treatment for Congenital Hyperinsulinism Keep Reading Jun 20, 2023 Twist Bioscience Appoints Chet Gandhi as Chief Information Officer Keep Reading May 31, 2023 Twist Bioscience and CeGaT Launch RNA Fusion Panel to Advance Oncology and Precision Medicine Research Keep Reading Current page 1 Page 2 Page 3 Next page next › Last page last »
Aug 31, 2023 Twist Bioscience Enters into Agreement with Ono Pharmaceutical to Discover Novel Antibodies for Autoimmune Diseases Keep Reading
Aug 22, 2023 Twist Bioscience Releases 2023 ESG Report and Quantifies Carbon Footprint of Manufacturing a Single Gene Keep Reading
Aug 07, 2023 Twist Bioscience to Present at the UBS MedTech, Tools and Genomics Summit 2023 Keep Reading
Jul 20, 2023 Twist Bioscience to Report Fiscal 2023 Third Quarter Financial Results on Friday, August 4, 2023 Keep Reading
Jul 18, 2023 Twist Bioscience and Cancer Research Horizons Enter into Collaboration to Advance Cancer Research Keep Reading
Jun 26, 2023 Twist Bioscience Publishes Preclinical Data in Diabetes Validating GLP-1R Antagonist Antibody as Potential Treatment for Congenital Hyperinsulinism Keep Reading
May 31, 2023 Twist Bioscience and CeGaT Launch RNA Fusion Panel to Advance Oncology and Precision Medicine Research Keep Reading
